Latest BioAlps news
News
Unlocking the New Window for Digital Health in the Swiss Health Valley
BioAlps – Swiss Health Valley and Deloitte Switzerland have joined forces to publish a new report, Unlocking the new window…
News
Edwards Lifesciences receives the BioAlps – Swiss Health Valley Industry Award at the BioAlps Networking Day 2026
BioAlps – Swiss Health Valley presented its Industry Award to Edwards Lifesciences, the leading global structural heart innovation company, today…
News
The HUG Vaccinology Centre receives the BioAlps – Swiss Health Valley Academia Award
The Vaccinology Centre of the Geneva University Hospitals (HUG) and the University of Geneva (UNIGE) is the 2026 winner of…
News
Datarium at BioAlps Networking Day
Exploring the data of life during the BioAlps Networking Day with the Datarium exhibition created by the Swiss Institute of…
News
Neurosterix Announces $105 Million Series B Financing
Neurosterix, a Geneva-based clinical-stage biotechnology company developing novel, selective allosteric modulators for neuropsychiatric disorders, announced the closing of a $105…
News
Bewe Lab Gets Support from Lichtsteiner Foundation
Changing eating and drinking habits doesn’t have to start with restriction. Bewe Lab, a spinoff of the University of Fribourg…
News
Swiss Biotech Association appoints Nicolas Durand as CEO and Odile Rundquist as Chief Strategy & Growth Officer
The Swiss Biotech Association has appointed Nicolas Durand as CEO, effective 1 January 2027, and Odile Rundquist as Chief Strategy & Growth Officer, as…
News
ExcellGene celebrates 25 years of biotechnology innovation
Based in Monthey (VS) since 2003, ExcellGene last week celebrated 25 years of biotechnology innovation also marking the leadership transition…
News
HUG to Lead a Major Trial Testing Cell Therapy for Advanced Heart Failure
Geneva University Hospitals (HUG) has received over CHF 1 million from the Swiss National Science Foundation to take part in…
News
Twice as many Swiss now ask AI about their symptoms
The 2026 CSS Health Study shows chatbots are fast becoming part of how people in Switzerland manage their health, from…
News
Ibex Therapeutics Secures CHF 640,000 in Grant Funding from Innosuisse
The Valais-based start-up is accelerating the development of its lead candidate in partnership with the Geneva University Hospitals (HUG) and…
News
Apolarion receives CHF 150,000 from Venture Kick
The EPFL spin-off Apolarion has obtained CHF 150,000 from Venture Kick to advance a chemical-free seed treatment technology powered by…











